Bravo
Payments companies reported to CMS as associated with Bravo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bravo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bravo
These are the largest totals companies reported as associated with Bravo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adam Arthur | Memphis, TN | Neurological Surgery | $13,017.50 |
| Jodie Barkin | Miami, FL | Gastroenterology (Internal Medicine) | $7,250.00 |
| John Pandolfino | Chicago, IL | Gastroenterology (Internal Medicine) | $6,050.00 |
| Michael Ujiki | Evanston, IL | Surgery | $5,415.82 |
| David Hass | Hamden, CT | Gastroenterology (Internal Medicine) | $4,500.00 |
| Abraham Khan | New York, NY | Gastroenterology (Internal Medicine) | $1,600.00 |
| Abdul Aadam | Chicago, IL | Gastroenterology (Internal Medicine) | $1,500.00 |
| Seth Gross | New York, NY | Gastroenterology (Internal Medicine) | $1,204.04 |
| Yalini Vigneswaran | Chicago, IL | Surgery | $275.01 |
| Shilpa Kailas | Chicago, IL | Gastroenterology (Internal Medicine) | $227.55 |
Prescribed Bravo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.